CaCCinh-A01 50 mg | 99.92%
TargetMol
CaCCinh-A01 is an inhibitor of the calcium-activated chloride channel (CaCC, 10 μM) and TMEM16A (IC50: 2.1 μM).
More Information Supplier PageCaCCinh-A01
Search Results
CIL56 10 mg | 99.91%
TargetMol
CIL56 is a small molecule that induces cellular ferroptosis through the production of iron-dependent reactive oxygen species (ROS). It also induces accumulation of long-chain saturated, monounsaturated, and polyunsaturated fatty acids in HT-1080 cells in vitro.HT-1080 cells lacking acetyl-CoA carboxylase 1 (ACC1), the rate-limiting enzyme in fatty acid synthesis, exhibit 5-fold resistance to CIL56 treatment, indicating […]
More Information Supplier PageCIL56
CIL56 5 mg | 99.91%
TargetMol
CIL56 is a small molecule that induces cellular ferroptosis through the production of iron-dependent reactive oxygen species (ROS). It also induces accumulation of long-chain saturated, monounsaturated, and polyunsaturated fatty acids in HT-1080 cells in vitro.HT-1080 cells lacking acetyl-CoA carboxylase 1 (ACC1), the rate-limiting enzyme in fatty acid synthesis, exhibit 5-fold resistance to CIL56 treatment, indicating […]
More Information Supplier PageCIL56
CIL56 2 mg | 99.91%
TargetMol
CIL56 is a small molecule that induces cellular ferroptosis through the production of iron-dependent reactive oxygen species (ROS). It also induces accumulation of long-chain saturated, monounsaturated, and polyunsaturated fatty acids in HT-1080 cells in vitro.HT-1080 cells lacking acetyl-CoA carboxylase 1 (ACC1), the rate-limiting enzyme in fatty acid synthesis, exhibit 5-fold resistance to CIL56 treatment, indicating […]
More Information Supplier PageCIL56
PF-06840003 50 mg | 99.89%
TargetMol
PF-06840003 (EOS200271) is a specific and oral active IDO-1 inhibitor.
More Information Supplier PagePF-06840003
PF-06840003 10 mg | 99.89%
TargetMol
PF-06840003 (EOS200271) is a specific and oral active IDO-1 inhibitor.
More Information Supplier PagePF-06840003
PF-06840003 5 mg | 99.89%
TargetMol
PF-06840003 (EOS200271) is a specific and oral active IDO-1 inhibitor.
More Information Supplier PagePF-06840003
PF-06840003 2 mg | 99.89%
TargetMol
PF-06840003 (EOS200271) is a specific and oral active IDO-1 inhibitor.
More Information Supplier PagePF-06840003
AZD2098 50 mg | 99.80%
TargetMol
AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor used for asthma research.
More Information Supplier PageAZD2098
CIL56 25 mg | 99.91%
TargetMol
CIL56 is a small molecule that induces cellular ferroptosis through the production of iron-dependent reactive oxygen species (ROS). It also induces accumulation of long-chain saturated, monounsaturated, and polyunsaturated fatty acids in HT-1080 cells in vitro.HT-1080 cells lacking acetyl-CoA carboxylase 1 (ACC1), the rate-limiting enzyme in fatty acid synthesis, exhibit 5-fold resistance to CIL56 treatment, indicating […]
More Information Supplier PageCIL56